Indeed, it has been reported CDK1 is the main target of WEE1 inhibitor which is involved in cytokinesis26–28, and WEE1 inhibitors have been effectively applied to antimicrotubule cancer drugs (AMCDs)29. This evidence concerns the gene CDK1 and cancer.